lobbying_activities: 3051269

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3051269	d6fc32b1-4034-4db4-a080-7d9ba6ebd1da	Q3	LUPIN PHARMACEUTICALS INC	401104766	LUPIN PHARMACEUTICALS INC	2023	third_quarter	PHA	Issues related to finished dose pharmaceutical reimbursement, pricing transparency, and drug disposal.	HOUSE OF REPRESENTATIVES,SENATE		105000	0	0	2023-10-16T14:17:04-04:00